NEW YORK (GenomeWeb News) – Researchers at The University of Texas, Austin and Southwestern University will use a $730,000 grant from the National Institutes of Health to develop a new method for rapidly screening blood samples for protein biomarkers, UT-Austin said last week.

The three-stage screening method will involve using a chip with capture agents that bind to specific compounds in a blood sample, an ultraviolet light to sever those chemical bonds, and an electrospray that transfers the compounds into a mass spectrometer for analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.